SPENDD 2
STUDY BASICS
Do you have pain in both of your feet from nerve damage (peripheral neuropathy)? You may be eligible for a research study to test whether a method to assess neuropathic pain characteristics can be used to classify patients into pain sub-groups and predict who will respond best to certain pain treatments that participants will take during this study. Compensation is provided.
STUDY PURPOSE
This research is studying:
- Whether certain tests that assess your pain can help predict which medication will work best for each person.
- How well two different medications work to reduce nerve pain in the feet.
COULD THIS STUDY BE RIGHT FOR YOU?
- Must be between 18 and 80 years old.
- Must have nerve pain in both of your feet due to peripheral neuropathy.
- Examples include pain from diabetes, chemotherapy, or unknown causes.
WHAT PARTICIPANTS CAN EXPECT
- You will try two different drugs (at different times) that are commonly used by doctors to treat pain.
- You will attend 5 study visits (1-2 hours) over 5 months.
- You will respond to questionnaires about your pain.
- You will undergo some tests that evaluate your pain
- You will provide a blood sample (not required).
IRB: STUDY00009806
- Sensory Phenotyping to Enhance Neuropathic pain Drug Development (SPENDD): A randomized, double-blinded cross-over clinical trial aimed at investigating whether bedside quantitative sensory testing can predict response to analgesics.MEET THE RESEARCHER
Ajay Wasan
Ajay D. Wasan, MD, MSc, is a Professor of Anesthesiology and Psychiatry at the University of Pittsburgh School of Medicine and Vice Chair for Pain Medicine in the Department of Anesthesiology at UPMC. A graduate of the University of Illinois College of Medicine, Dr. Wasan has a particular expertise in interventional procedures, neuropathic pain medications, and psychiatric co-morbidities of chronic pain.
https://pittplusme.org/study/spendd2